TARA Protara Therapeutics, Inc.
Nasdaq · SEC CIK 1359931 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.01M 3 sales by 2 insiders
- Filings on record
- 137 since 2021-11-08, latest 2026-07-01 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Shefferman Jesse | CEO, Pres, Dir | — | $882.2K |
| Zummo Jacqueline | Chief R, D Off | — | $125.0K |
| Nicacio Leonardo Viana | Chief Medical Off | — | — |
| Fry Hannah | VP, Ctrl | — | — |
| CONKLING WILLIAM | Chief Commercial Off | — | — |
| Fabbio Patrick | CFO | — | — |
Transactions 102
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Shefferman Jesse | CEO, Pres, Dir | M - OptEx | $1.91 | +215.7K | 937.5K | +30% | +$412.0K |
| D | 2026-07-01 16:10 | 2026-06-29 | TARA | Shefferman Jesse | CEO, Pres, Dir | S - Sale+OE | $4.09 | -215.7K | 721.8K | -23% | -$882.2K |
| DM | 2026-07-01 16:10 | 2026-06-30 | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -30.0K | 691.8K | -4% | $0 |
| 2026-06-03 16:55 | 2026-06-02 | TARA | CONKLING WILLIAM | Chief Commercial Off | F - Tax | $4.34 | -6,008 | 70.0K | -8% | -$26.1K | |
| 2026-04-09 17:25 | 2026-04-08 | TARA | Zummo Jacqueline | Chief R, D Off | S - Sale | $5.40 | -1,134 | 94.8K | -1% | -$6,124 | |
| 2026-04-02 16:05 | 2026-04-01 | TARA | Zummo Jacqueline | Chief R, D Off | S - Sale | $5.26 | -22.6K | 96.0K | -19% | -$118.9K | |
| 2026-01-27 | 2026-01-26 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $6.67 | -1,457 | 42.7K | -3% | -$9,718 | |
| 2026-01-27 | 2026-01-26 | TARA | Fabbio Patrick | CFO | F - Tax | $6.67 | -3,261 | 64.1K | -5% | -$21.8K | |
| 2026-01-27 | 2026-01-26 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $6.67 | -3,724 | 118.6K | -3% | -$24.8K | |
| 2026-01-27 | 2026-01-26 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $6.67 | -8,732 | 1.02M | -0.8% | -$58.2K | |
| 2026-01-22 | 2026-01-20 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $5.60 | -6,578 | 122.3K | -5% | -$36.8K | |
| 2026-01-22 | 2026-01-20 | TARA | Fabbio Patrick | CFO | F - Tax | $5.60 | -3,063 | 67.4K | -4% | -$17.2K | |
| 2026-01-22 | 2026-01-20 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $5.60 | -2,132 | 44.2K | -5% | -$11.9K | |
| 2026-01-22 | 2026-01-20 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $5.60 | -16.3K | 1.03M | -2% | -$91.4K | |
| D | 2026-01-21 | 2026-01-16 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +30.0K | 128.9K | +30% | $0 |
| D | 2026-01-21 | 2026-01-16 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +28.0K | 70.4K | +66% | $0 |
| D | 2026-01-21 | 2026-01-16 | TARA | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +87.0K | 1.05M | +9% | $0 |
| D | 2026-01-21 | 2026-01-16 | TARA | CONKLING WILLIAM | Chief Commercial Off | A - Grant | $0.00 | +26.0K | 76.0K | +52% | $0 |
| D | 2026-01-21 | 2026-01-16 | TARA | Nicacio Leonardo Viana | Chief Medical Off | A - Grant | $0.00 | +26.0K | 78.2K | +50% | $0 |
| D | 2026-01-21 | 2026-01-16 | TARA | Fry Hannah | VP, Ctrl | A - Grant | $0.00 | +9,500 | 46.3K | +26% | $0 |
| 2025-07-07 | 2025-06-24 | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -300.0K | 659.9K | -31% | $0 | |
| M | 2025-06-30 | 2025-06-26+ | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -18.7K | 963.3K | -2% | $0 |
| D | 2025-06-04 | 2025-06-02 | TARA | CONKLING WILLIAM | Chief Commercial Off | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| A | 2025-05-19 | 2025-05-14 | TARA | Levy Richard S | Dir | P - Purchase | $3.19 | +20.0K | 51.0K | +65% | +$63.8K |
| 2025-05-16 | 2025-05-14 | TARA | Levy Richard S | Dir | P - Purchase | $3.19 | +20.0K | 51.0K | +65% | +$63.8K | |
| D | 2025-04-17 | 2025-04-15 | TARA | Nicacio Leonardo Viana | Chief Medical Off | A - Grant | $0.00 | +50.0K | 52.2K | +2,293% | $0 |
| 2025-03-28 | 2025-03-26 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | S - Sale | $4.53 | -21.2K | 98.9K | -18% | -$96.1K | |
| D | 2025-01-28 | 2025-01-24 | TARA | Fry Hannah | VP, Ctrl | A - Grant | $0.00 | +9,500 | 38.9K | +32% | $0 |
| D | 2025-01-28 | 2025-01-24 | TARA | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +65.0K | 994.0K | +7% | $0 |
| D | 2025-01-28 | 2025-01-24 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +24.5K | 126.6K | +24% | $0 |
| D | 2025-01-28 | 2025-01-24 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +23.5K | 45.5K | +107% | $0 |
| 2025-01-23 | 2025-01-21 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $4.76 | -2,130 | 27.3K | -7% | -$10.1K | |
| 2025-01-23 | 2025-01-21 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $4.76 | -6,554 | 95.6K | -6% | -$31.2K | |
| 2025-01-23 | 2025-01-21 | TARA | Fabbio Patrick | CFO | F - Tax | $4.76 | -3,061 | 18.9K | -14% | -$14.6K | |
| 2025-01-23 | 2025-01-21 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $4.76 | -15.5K | 913.6K | -2% | -$73.6K | |
| 2025-01-07 | 2025-01-03 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $6.14 | -2,157 | 102.1K | -2% | -$13.2K | |
| 2025-01-07 | 2025-01-03 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $6.14 | -6,479 | 929.0K | -0.7% | -$39.8K | |
| 2025-01-07 | 2025-01-03 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $6.14 | -394 | 29.4K | -1% | -$2,419 | |
| MI | 2024-09-12 | 2024-09-11+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $1.71 | -158.9K | 51.5K | -76% | -$271.7K |
| MI | 2024-09-10 | 2024-09-09+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $1.84 | -62.0K | 53.1K | -54% | -$114.1K |
| M | 2024-08-30 | 2024-08-28 | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -8,563 | 935.5K | -0.9% | $0 |
| MI | 2024-07-18 | 2024-07-16 | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.44 | -11.4K | 56.5K | -17% | -$27.8K |
| MI | 2024-07-11 | 2024-07-09+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.36 | -74.6K | 60.0K | -55% | -$175.7K |
| MI | 2024-07-03 | 2024-07-01 | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.12 | -8,288 | 87.5K | -9% | -$17.6K |
| MI | 2024-06-28 | 2024-06-27+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.21 | -64.6K | 2.23M | -3% | -$142.5K |
| MI | 2024-06-27 | 2024-06-25 | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.26 | -12.7K | 102.5K | -11% | -$28.8K |
| MI | 2024-05-31 | 2024-05-30+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.92 | -15.1K | 108.7K | -12% | -$44.0K |
| MI | 2024-05-23 | 2024-05-21+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $3.05 | -42.8K | 124.2K | -26% | -$130.6K |
| MI | 2024-05-17 | 2024-05-17 | TARA | Opaleye Management Inc. | 10% | S - Sale | $3.25 | -70.9K | 2.31M | -3% | -$230.4K |
| MI | 2024-05-10 | 2024-05-09+ | TARA | Opaleye Management Inc. | 10% | S - Sale | $3.11 | -182.3K | 2.38M | -7% | -$566.3K |
| D | 2024-01-23 | 2024-01-19 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +22.0K | 22.0K | New | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +59.0K | 951.9K | +7% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $1.91 | -7,803 | 944.1K | -0.8% | -$14.9K |
| D | 2024-01-23 | 2024-01-19 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +23.0K | 107.3K | +27% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $1.91 | -3,049 | 104.3K | -3% | -$5,824 |
| D | 2024-01-23 | 2024-01-19 | TARA | Bandari Jathin | Chief Medical Off | A - Grant | $0.00 | +23.0K | 59.6K | +63% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Bandari Jathin | Chief Medical Off | F - Tax | $1.91 | -2,879 | 56.7K | -5% | -$5,499 |
| D | 2024-01-23 | 2024-01-19 | TARA | Fry Hannah | VP, Ctrl | A - Grant | $0.00 | +8,000 | 30.7K | +35% | $0 |
| D | 2024-01-23 | 2024-01-19 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $1.91 | -904 | 29.8K | -3% | -$1,727 |
| 2024-01-12 | 2024-01-10 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $2.39 | -5,229 | 84.3K | -6% | -$12.5K | |
| 2024-01-12 | 2024-01-10 | TARA | Bandari Jathin | Chief Medical Off | F - Tax | $2.39 | -1,877 | 36.6K | -5% | -$4,486 | |
| 2024-01-12 | 2024-01-10 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.39 | -5,746 | 892.9K | -0.6% | -$13.7K | |
| 2024-01-05 | 2024-01-03 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $2.17 | -324 | 22.7K | -1% | -$703.08 | |
| 2024-01-05 | 2024-01-03 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.17 | -5,840 | 898.6K | -0.6% | -$12.7K | |
| 2024-01-05 | 2024-01-03 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $2.17 | -1,899 | 89.6K | -2% | -$4,121 | |
| 2023-07-18 | 2023-07-17 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $2.56 | -10.1K | 23.1K | -30% | -$25.8K | |
| 2023-07-05 | 2023-07-03 | TARA | Bandari Jathin | Chief Medical Off | F - Tax | $2.46 | -682 | 38.5K | -2% | -$1,678 | |
| M | 2023-06-27 | 2023-06-23+ | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -9,310 | 911.9K | -1% | $0 |
| D | 2023-01-20 | 2023-01-19 | TARA | Fry Hannah | VP, Ctrl | A - Grant | $0.00 | +5,900 | 33.1K | +22% | $0 |
| D | 2023-01-20 | 2023-01-19 | TARA | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +51.3K | 918.3K | +6% | $0 |
| D | 2023-01-20 | 2023-01-19 | TARA | Bandari Jathin | Chief Medical Off | A - Grant | $0.00 | +20.7K | 39.1K | +112% | $0 |
| D | 2023-01-20 | 2023-01-19 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +19.9K | 91.5K | +28% | $0 |
| 2023-01-11 | 2023-01-10 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $3.00 | -5,225 | 71.6K | -7% | -$15.7K | |
| 2023-01-11 | 2023-01-10 | TARA | Bandari Jathin | Chief Medical Off | F - Tax | $3.00 | -1,876 | 18.4K | -9% | -$5,628 | |
| 2023-01-11 | 2023-01-10 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $3.00 | -5,855 | 867.0K | -0.7% | -$17.6K | |
| 2023-01-04 | 2023-01-03 | TARA | Fry Hannah | VP, Ctrl | F - Tax | $2.80 | -361 | 27.2K | -1% | -$1,011 | |
| 2023-01-04 | 2023-01-03 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.80 | -6,604 | 872.8K | -0.8% | -$18.5K | |
| 2023-01-04 | 2023-01-03 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $2.80 | -2,159 | 76.8K | -3% | -$6,045 | |
| MI | 2022-12-30 | 2022-12-30 | TARA | Opaleye Management Inc. | 10% | S - Sale | $2.71 | +15.5K | 130.0K | +14% | +$41.9K |
| MI | 2022-09-15 | 2022-09-14+ | TARA | Opaleye Management Inc. | 10% | P - Purchase | $3.93 | +23.9K | 2.58M | +0.9% | +$93.8K |
| 2022-08-15 | 2022-08-11 | TARA | Shefferman Jesse | CEO, Pres, Dir | P - Purchase | $3.84 | +9,065 | 879.4K | +1% | +$34.8K | |
| 2022-07-19 | 2022-07-15 | TARA | Davis Blaine | CFO | F - Tax | $3.13 | -5,081 | 20.7K | -20% | -$15.9K | |
| 2022-07-19 | 2022-07-16 | TARA | Fry Hannah | VP, Ctrl | A - Grant | $0.00 | +25.0K | 27.6K | +962% | $0 | |
| 2022-07-05 | 2022-07-01 | TARA | Bandari Jathin | Chief Medical Off | F - Tax | $3.22 | -682 | 20.3K | -3% | -$2,196 | |
| 2022-07-05 | 2022-06-30 | TARA | BESHAR LUKE M | Dir | P - Purchase | $3.10 | +10.0K | 198.0K | +5% | +$31.0K | |
| MAI | 2022-04-15 | 2022-04-07+ | TARA | Opaleye Management Inc. | 10% | P - Purchase | $4.79 | +10.1K | 125.0K | +9% | +$48.5K |
| MI | 2022-04-08 | 2022-04-07+ | TARA | Opaleye Management Inc. | 10% | P - Purchase | $4.79 | +10.1K | 125.0K | +9% | +$48.5K |
| 2022-03-16 | 2022-03-14 | TARA | BESHAR LUKE M | Dir | P - Purchase | $4.25 | +10.0K | 188.0K | +6% | +$42.5K | |
| 2022-03-14 | 2022-03-10 | TARA | BESHAR LUKE M | Dir | P - Purchase | $4.46 | +10.0K | 178.0K | +6% | +$44.6K | |
| MI | 2022-01-31 | 2022-01-28 | TARA | Opaleye Management Inc. | 10% | P - Purchase | $4.96 | +24.0K | 2.55M | +1.0% | +$119.2K |
| 2022-01-12 | 2022-01-10 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $6.27 | -5,080 | 872.4K | -0.6% | -$31.9K | |
| 2022-01-12 | 2022-01-10 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | F - Tax | $6.27 | -4,603 | 79.0K | -6% | -$28.9K | |
| D | 2022-01-12 | 2022-01-10 | TARA | Bandari Jathin | Chief Medical Off | A - Grant | $0.00 | +13.5K | 13.5K | New | $0 |
| D | 2022-01-05 | 2022-01-03 | TARA | Zummo Jacqueline | Chf Scientific Ops Off | A - Grant | $0.00 | +14.1K | 83.6K | +20% | $0 |
| D | 2022-01-05 | 2022-01-03 | TARA | Shefferman Jesse | CEO, Pres, Dir | A - Grant | $0.00 | +42.3K | 877.5K | +5% | $0 |
| D | 2022-01-05 | 2022-01-03 | TARA | Davis Blaine | CFO | A - Grant | $0.00 | +14.1K | 15.6K | +952% | $0 |
| MI | 2021-12-29 | 2021-12-28+ | TARA | Opaleye Management Inc. | 10% | P - Purchase | $6.60 | +11.6K | 2.53M | +0.5% | +$76.5K |
| MI | 2021-12-27 | 2021-12-23+ | TARA | Opaleye Management Inc. | 10% | P - Purchase | $6.53 | +38.0K | 105.0K | +57% | +$248.2K |
| I | 2021-12-22 | 2021-12-20 | TARA | Opaleye Management Inc. | 10% | P - Purchase | $6.49 | +703 | 2.50M | +0.0% | +$4,562 |
| MI | 2021-12-20 | 2021-12-16+ | TARA | Opaleye Management Inc. | 10% | P - Purchase | $6.46 | +10.4K | 2.50M | +0.4% | +$66.9K |
Purchase Sale Sale after option exercise All abbreviations